Management of localized kidney cancer: Calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management

European Urology

Volumn 65, Issue 1, 2014, Pages 235-241

  Sun, Maxine ^a,b   Becker, Andreas ^a,c   Tian, Zhe ^a   Roghmann, Florian ^a,d   Abdollah, Firas ^a,e   Larouche, Alexandre ^a   Karakiewicz, Pierre I ^a   Trinh, Quoc Dien ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Localized kidney cancer; Nephrectomy; Nonsurgical management; SEER

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SPECIFIC MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEPHRECTOMY; NONSURGICAL MANAGEMENT; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADICAL NEPHRECTOMY; CARCINOMA, RENAL CELL; COMPARATIVE STUDY; KIDNEY NEOPLASMS; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEPHRECTOMY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84888842440     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.03.034     Document Type: Article

References (30)

1. B. Ljungberg, N.C. Cowan, and D.C. Hanbury EAU guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
2. S.C. Campbell, A.C. Novick, A. Belldegrun Practice Guidelines Committee of the American Urological Association Guideline for management of the clinical T1 renal mass J Urol 182 2009 1271 1279
3. NCCN clinical practice guidelines in oncology. Kidney cancer [p. 1-30]. National Comprehensive Cancer Network Web site. http://www.nccn.org/ professionals/physician-gls/pdf/kidney.pdf.
4. M. Sun, F. Abdollah, and M. Bianchi Treatment management of small renal masses in the 21st century: a paradigm shift Ann Surg Oncol 19 2012 2380 2387
5. M. Sun, R. Thuret, and F. Abdollah Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis Eur Urol 59 2011 135 141
6. S.N. Chawla, P.L. Crispen, A.L. Hanlon, R.E. Greenberg, D.Y.T. Chen, and R.G. Uzzo The natural history of observed enhancing renal masses: meta-analysis and review of the world literature J Urol 175 2006 425 431
7. R. Abouassaly, B.R. Lane, and A.C. Novick Active surveillance of renal masses in elderly patients J Urol 180 2008 505 508 discussion 508-9
8. B.R. Lane, D. Babineau, and M.W. Kattan A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy J Urol 178 2007 429 434
9. M.C. Smaldone, A. Kutikov, and B.L. Egleston Small renal masses progressing to metastases under active surveillance Cancer 118 2011 997 1006
10. J.M. Hollingsworth, D.C. Miller, S. Daignault, and B.K. Hollenbeck Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763 1768
11. A. Kutikov, B.L. Egleston, Y.-N. Wong, and R.G. Uzzo Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311 317
12. B.R. Lane, R. Abouassaly, and T. Gao Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older Cancer 116 2010 3119 3126
13. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3-18
14. E.A. Engels, R.M. Pfeiffer, W. Ricker, W. Wheeler, R. Parsons, and J.L. Warren Use of surveillance, epidemiology, and end results-Medicare data to conduct case-control studies of cancer among the US elderly Am J Epidemiol 174 2011 860 870
15. M. Sun, Q.-D. Trinh, and M. Bianchi A non-cancer-related survival benefit is associated with partial nephrectomy Eur Urol 61 2012 725 731
16. H.-J. Tan, E.C. Norton, Z. Ye, K.S. Hafez, J.L. Gore, and D.C. Miller Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer JAMA 307 2012 1629 1635
17. M. Sun, F. Abdollah, and D. Liberman Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis Cancer 117 2011 4277 4285
18. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
19. J.P. Newhouse, and M. McClellan Econometrics in outcomes research: the use of instrumental variables Annu Rev Public Health 19 1998 17 34
20. D.M. Makuc, B. Haglund, D.D. Ingram, J.C. Kleinman, and J.J. Feldman Health service areas for the United States Vital Health Stat 2 112 1991 1 102
21. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
22. A. Hurria, I.S. Browner, and H.J. Cohen Senior adult oncology J Natl Compr Canc Netw 10 2012 162 209
23. T.K. Choueiri, F.A.B. Schutz, and N.D. Hevelone Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis Urology 78 2011 93 98
24. W.C. Huang, A.S. Levey, and A.M. Serio Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study Lancet Oncol 7 2006 735 740
25. M. Sun, M. Bianchi, and J. Hansen Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis Eur Urol 62 2012 696 703
26. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.-Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
27. A.S. Levey, and J. Coresh Chronic kidney disease Lancet 379 2012 165 180
28. P.L. Crispen, R. Viterbo, E.B. Fox, R.E. Greenberg, D.Y.T. Chen, and R.G. Uzzo Delayed intervention of sporadic renal masses undergoing active surveillance Cancer 112 2008 1051 1057
29. E.L. Korn, and B. Freidlin Methodology for comparative effectiveness research: potential and limitations J Clin Oncol 30 2012 4185 4187
30. D.F. Penson, P.C. Albertsen, P.S. Nelson, M. Barry, and J.L. Stanford Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 93 2001 1822 1823